- Home
- PACB vs PNNT Comparison
PACB vs PNNT Comparison
Compare PACB & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- PNNT
- Stock Information
- Founded
- PACB 2000
- PNNT 2007
- Country
- PACB United States
- PNNT United States
- Employees
- PACB N/A
- PNNT N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- PNNT Finance: Consumer Services
- Sector
- PACB Industrials
- PNNT Finance
- Exchange
- PACB Nasdaq
- PNNT Nasdaq
- Market Cap
- PACB 381.5M
- PNNT 457.1M
- IPO Year
- PACB 2010
- PNNT 2007
- Fundamental
- Price
- PACB $1.23
- PNNT $6.80
- Analyst Decision
- PACB Buy
- PNNT Sell
- Analyst Count
- PACB 7
- PNNT 4
- Target Price
- PACB $1.90
- PNNT $6.33
- AVG Volume (30 Days)
- PACB 5.1M
- PNNT 459.7K
- Earning Date
- PACB 11-06-2025
- PNNT 08-11-2025
- Dividend Yield
- PACB N/A
- PNNT 14.07%
- EPS Growth
- PACB N/A
- PNNT 21.65
- EPS
- PACB N/A
- PNNT 0.80
- Revenue
- PACB $156,110,000.00
- PNNT $130,923,000.00
- Revenue This Year
- PACB $6.15
- PNNT N/A
- Revenue Next Year
- PACB $15.68
- PNNT N/A
- P/E Ratio
- PACB N/A
- PNNT $8.56
- Revenue Growth
- PACB N/A
- PNNT N/A
- 52 Week Low
- PACB $0.85
- PNNT $5.72
- 52 Week High
- PACB $2.72
- PNNT $7.53
- Technical
- Relative Strength Index (RSI)
- PACB 45.49
- PNNT 25.76
- Support Level
- PACB $1.15
- PNNT $7.11
- Resistance Level
- PACB $1.32
- PNNT $7.29
- Average True Range (ATR)
- PACB 0.07
- PNNT 0.09
- MACD
- PACB -0.00
- PNNT -0.04
- Stochastic Oscillator
- PACB 40.00
- PNNT 1.00
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.